Latest stories on KMDA
Kamada to Present at the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire56 · neutralgeneral
Kamada to Present at the H.C. Wainwright 28th Annual Global Investment Conference
StockTitan55 · neutralgeneral
Kamada files to sell $50M of ordinary shares
The Fly24 · bearishgeneral
Kamada declares $0.17 dividend
Seeking Alpha50 · neutralgeneral
Kamada Updates on Withholding Tax Procedures on Previously Announced Cash Dividend to Shareholders
GlobeNewswire50 · neutralgeneral
Kamada (KMDA) Q2 2026 Earnings Call Transcript
Yahoo Top73 · bullishearnings
Kamada (KMDA) Q2 2026 Earnings Call Transcript
The Motley Fool73 · bullishearnings
Kamada declares $0.17 dividend
Seeking Alpha50 · neutralgeneral
Kamada Declares Cash Dividend of $0.17 Per Share; The Company Reported Record-High Revenue and Profitability for First Six Months of 2026
Business Insider59 · neutralgeneral
Kamada Ltd. Q2 2026 Earnings Call Summary
Yahoo Top50 · neutralearnings
Kamada Ltd. (KMDA) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Kamada Q2 Earnings Call Highlights
Yahoo Finance67 · bullishearnings
Kamada Posts Record Revenues and Double-Digit Profit Growth, Affirms 2026 Guidance Amid Portfolio Expansion
August 12, 2026
MarketChameleon76 · bullishearnings
Kamada CFO to Depart, 2Q Sales Rise
MarketWatch48 · neutralgeneral
Kamada CFO Chaime Orlev to step down
Seeking Alpha47 · neutralgeneral
Kamada GAAP EPS of $0.16 beats by $0.05, revenue of $54.9M beats by $5.8M
Seeking Alpha68 · bullishearnings
Kamada Announces Planned Transition of Chief Financial Officer
GlobeNewswire50 · neutralgeneral
Kamada Announces Planned Transition of Chief Financial Officer
Business Insider50 · neutralgeneral
Kamada Q2 2026 Earnings Preview
Seeking Alpha55 · neutralearnings
Kamada to Announce Second Quarter and First Half Ended June 30, 2026 Financial Results on August 12, 2026
Business Insider50 · neutralgeneral
Kamada stock holds at Buy as Benchmark cites $50M plasma deal
Investing.com Analyst Ratings61 · neutralgeneral
Kamada Announces a Three-Year $50 Million Sales Agreement to Supply Plasma to a Leading Biopharmaceutical Company focused on Plasma-derived Therapies
Business Insider63 · neutralproduct/pr